Average Co-Inventor Count = 10.00
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (20 from 2,405 patents)
2. Lycera Corporation (5 from 36 patents)
3. Leland Stanford Junior University (3 from 5,303 patents)
4. Merck Canada Inc. (3 from 40 patents)
23 patents:
1. 11685761 - Cyclic di-nucleotide compounds as sting agonists
2. 11453697 - Cyclic di-nucleotide compounds as sting agonists
3. 10766919 - Cyclic di-nucleotide compounds as sting agonists
4. 10759825 - Cyclic di-nucleotide compounds as STING agonists
5. 10745364 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
6. 10738074 - Cyclic di-nucleotide compounds as STING agonists
7. 10513525 - Methods and compositions for studying, imaging, and treating pain
8. 10246457 - Indazole and azaindazole Btk inhibitors
9. 10221146 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
10. 10208047 - Tertiary alcohol imidazopyrazine BTK inhibitors
11. 9969749 - Inhibitors of IRAK4 activity
12. 9943516 - Inhibitors of IRAK4 activity
13. 9822107 - Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
14. 9809561 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
15. 9783511 - Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease